Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity | Citedby Results | Acta Cytologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity

Acta Cytologica (2021) 65 (2): 165–174.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Preclinical-to-Clinical Anti-Cancer Drug Response Prediction and Biomarker Identification Using TINDL

David Earl Hostallero
Lixuan Wei
Liewei Wang
Junmei Cairns
Amin Emad

Genomics, Proteomics & Bioinformatics (2023) 21 (3): 535.

An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma

Tianxiang Geng
Mengxue Zheng
Yongfeng Wang
Janne Elin Reseland
Athina Samara

Frontiers in Molecular Biosciences (2023) 10

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer

Weiyu Lu
Biao Xie
Guangqing Tan
Wanying Dai
Jingyi Ren
Sadaf Pervaz
Kun Li
Fangfang Li
Yingxiong Wang
Meijiao Wang

Frontiers in Endocrinology (2023) 14

Roles of Antimicrobial Peptides in Gynecological Cancers

Chongyi Zhao
Shuo Yan
Yuzhu Song
Xueshan Xia

International Journal of Molecular Sciences (2022) 23 (17): 10104.

The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity

Ya Wang
Xiaoli Wang
Meiling Zhu
Li Ge
Xiaochen Liu
Kaikai Su
Zhengzheng Chen
Weidong Zhao

Frontiers in Immunology (2022) 13

Identification of Potential Key Biomarkers and Immune Infiltration in Oral Lichen Planus

Lou Geng
Xingming Zhang
Yi Tang
Wenli Gu
Prasenjit Mitra

Disease Markers (2022) 2022: 1.